182 related articles for article (PubMed ID: 38108611)
1. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C; Pascale MR; Vitale A; Diral E; Tomelleri A; Galossi E; Falconi G; Bruno A; Crisafulli F; Frassi M; Cattaneo C; Bertoli D; Bernardi M; Condorelli A; Morsia E; Poloni A; Crisà E; Caravelli D; Triggianese P; Brussino L; Battipaglia G; Bindoli S; Sfriso P; Caroni F; Dragani M; Mallegni F; Pilo F; Firinu D; Curti A; Papayannidis C; Olivieri A; Kordasti S; Albano F; Pane F; Musto P; Bocchia M; Lugli E; Breccia M; Frigeni M; Dagna L; Greco R; Franceschini F; Campochiaro C; Cantarini L; Voso MT
Am J Hematol; 2024 Feb; 99(2):254-262. PubMed ID: 38108611
[TBL] [Abstract][Full Text] [Related]
2. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
[TBL] [Abstract][Full Text] [Related]
4. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Obiorah IE; Patel BA; Groarke EM; Wang W; Trick M; Ombrello AK; Ferrada MA; Wu Z; Gutierrez-Rodrigues F; Lotter J; Wilson L; Hoffmann P; Cardona DO; Patel N; Dulau-Florea A; Kastner DL; Grayson PC; Beck DB; Young NS; Calvo KR
Blood Adv; 2021 Aug; 5(16):3203-3215. PubMed ID: 34427584
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of VEXAS syndrome].
Gunnarsson K; Vivar Pomiano N; Tesi B; Tobiasson M; Creignou M; Ungerstedt J
Lakartidningen; 2022 Sep; 119():. PubMed ID: 36082915
[TBL] [Abstract][Full Text] [Related]
7. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N; Dulau-Florea A; Calvo KR
Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Sirenko M; Bernard E; Creignou M; Domenico D; Farina A; Arango Ossa JE; Kosmider O; Hasserjian RP; Jädersten M; Germing U; Sanz GF; van de Loosdrecht AA; Gurnari C; Follo MY; Thol FR; Zamora L; Pinheiro RF; Pellagatti A; Elias HK; Haase DT; Sander B; Orna E; Zoldan K; Eder LN; Sperr WR; Thalhammer R; Ganster C; Adès L; Tobiasson M; Palomo L; Della Porta MG; Huberman KH; Fenaux P; Belickova M; Savona MR; Klimek V; Santos FPS; Boultwood J; Kotsianidis I; Santini V; Sole F; Platzbecker U; Heuser M; Valent P; Finelli C; Voso MT; Shih LY; Ogawa S; Fontenay M; Jansen JH; Cervera J; Ebert BL; Bejar R; Greenberg PL; Gattermann N; Malcovati L; Cazzola M; Beck DB; Hellstrom-Lindberg ES; Papaemmanuil E
Blood; 2024 Apr; ():. PubMed ID: 38687605
[TBL] [Abstract][Full Text] [Related]
10. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
11. Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
Kataoka A; Mizumoto C; Kanda J; Iwasaki M; Sakurada M; Oka T; Fujimoto M; Yamamoto Y; Yamashita K; Nannya Y; Ogawa S; Takaori-Kondo A
Int J Hematol; 2023 Jun; 117(6):919-924. PubMed ID: 36641501
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
Front Immunol; 2022; 13():897722. PubMed ID: 35757758
[TBL] [Abstract][Full Text] [Related]
13. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and genetic features of MDS associated with VEXAS syndrome].
Kunimoto H
Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
[TBL] [Abstract][Full Text] [Related]
15. VEXAS syndrome with progression of MDS to MDS/MPN overlap syndrome.
Neupane K; Jayarangaiah A; Zhang Y; Kumar A
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549759
[TBL] [Abstract][Full Text] [Related]
16. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of clonal hematopoiesis in VEXAS syndrome.
Gutierrez-Rodrigues F; Kusne Y; Fernandez J; Lasho T; Shalhoub R; Ma X; Alessi H; Finke C; Koster MJ; Mangaonkar A; Warrington KJ; Begna K; Xie Z; Ombrello AK; Viswanatha D; Ferrada M; Wilson L; Go R; Kourelis T; Reichard K; Olteanu H; Darden I; Hironaka D; Alemu L; Kajigaya S; Rosenzweig S; Calado RT; Groarke EM; Kastner DL; Calvo KR; Wu CO; Grayson PC; Young NS; Beck DB; Patel BA; Patnaik MM
Blood; 2023 Jul; 142(3):244-259. PubMed ID: 37084382
[TBL] [Abstract][Full Text] [Related]
18. Accurate stratification between VEXAS syndrome and differential diagnoses by deep learning analysis of peripheral blood smears.
Chabrun F; Lacombe V; Dieu X; Geneviève F; Urbanski G
Clin Chem Lab Med; 2023 Jun; 61(7):1275-1279. PubMed ID: 36722042
[TBL] [Abstract][Full Text] [Related]
19. VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.
Kreutzinger V; Pankow A; Boyadzhieva Z; Schneider U; Ziegeler K; Stephan LU; Kübke JC; Schröder S; Oberender C; le Coutre P; Stintzing S; Jelas I
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398362
[TBL] [Abstract][Full Text] [Related]
20. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Koster MJ; Lasho TL; Olteanu H; Reichard KK; Mangaonkar A; Warrington KJ; Patnaik MM
Am J Hematol; 2024 Feb; 99(2):284-299. PubMed ID: 37950858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]